TRUE Stock Overview
Treatment.Com International Inc. provides personalized health care information services in Canada. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Treatment.com AI Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.54 |
52 Week High | CA$1.11 |
52 Week Low | CA$0.35 |
Beta | -0.45 |
11 Month Change | -21.74% |
3 Month Change | -31.65% |
1 Year Change | 5.88% |
33 Year Change | -96.12% |
5 Year Change | n/a |
Change since IPO | -98.29% |
Recent News & Updates
Shareholder Returns
TRUE | CA Healthcare Services | CA Market | |
---|---|---|---|
7D | -3.6% | 0.2% | 0.7% |
1Y | 5.9% | 97.0% | 21.7% |
Return vs Industry: TRUE underperformed the Canadian Healthcare Services industry which returned 98.2% over the past year.
Return vs Market: TRUE underperformed the Canadian Market which returned 21.4% over the past year.
Price Volatility
TRUE volatility | |
---|---|
TRUE Average Weekly Movement | 7.3% |
Healthcare Services Industry Average Movement | 8.1% |
Market Average Movement | 8.3% |
10% most volatile stocks in CA Market | 17.6% |
10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: TRUE has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: TRUE's weekly volatility has decreased from 14% to 7% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2018 | n/a | Essam Hamza | www.treatment.com |
Treatment Com International Inc. provides personalized health care information services in Canada. The company develops a mobile application for symptom assessment of users to address their health concerns, problems, and ongoing wellness management.
Treatment.com AI Inc. Fundamentals Summary
TRUE fundamental statistics | |
---|---|
Market cap | CA$26.86m |
Earnings (TTM) | -CA$2.01m |
Revenue (TTM) | CA$38.14k |
691.6x
P/S Ratio-13.1x
P/E RatioIs TRUE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
TRUE income statement (TTM) | |
---|---|
Revenue | CA$38.14k |
Cost of Revenue | CA$13.95k |
Gross Profit | CA$24.19k |
Other Expenses | CA$2.03m |
Earnings | -CA$2.01m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.041 |
Gross Margin | 63.43% |
Net Profit Margin | -5,268.63% |
Debt/Equity Ratio | -91.6% |
How did TRUE perform over the long term?
See historical performance and comparison